Tuberculosis (TB) Drugs Market: Information by Disease Type (Active TB, Latent TB), Therapy (First-Line, Second-Line) and Regional Outlook - Forecast Till 2026

May 21, 2019   Global Statistics Representing Tuberculosis (TB) Drugs Market Scenario Tuberculosis is caused by the Mycobacterium tuberculosis bacterium. It spreads when a person with active TB coughs or sneezes and the bacteria come in contact with a healthy person. A weakened immune system is the key cause of tuberculosis prevalence. According to the Central for Diseases Control and Prevention, around one-fourth of the world's population is infected with TB. Further, TB is a va...
Request Free Sample Report

Tables and figures

LIST OF TABLES

TABLE 1           Global Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 2           Active TB Tuberculosis Drug Market Share by Region, 2016–2026 ($Million)

TABLE 3           Latent TB Tuberculosis Drug Market Share by Region, 2016–2026 ($Million)

TABLE 4           Global Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 5           Global Tuberculosis Drug Market by Region, 2016–2026 ($Million)

TABLE 6           Global Tuberculosis Drug Market Share Value, 2016–2026 ($Million)

TABLE 7           America Tuberculosis Drug Market Share Value by Country, 2016–2026 ($Million)

TABLE 8           America Tuberculosis Drug Market Share Value by Disease Type, 2016–2026 ($Million)

TABLE 9           America Tuberculosis Drug Market Share Value by Therapy, 2016–2026 ($Million)

TABLE 10         U.S. Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 11         U.S. Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 12         Canada Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 13         Canada Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 14         Mexico Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 15         Mexico Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 16         Latin America Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 17         Latin America Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 18         Europe Tuberculosis Drug Market Share Value by Country, 2016–2026 ($Million)

TABLE 19         Europe Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 20         Europe Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 21         Germany Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 22         Germany Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 23         France Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 24         France Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 25         U.K. Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 26         U.K. Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 27         Italy Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 28         Italy Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 29         Spain Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 30         Spain Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 31         Rest of Europe Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 32         Rest of Europe Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 33         Asia-Pacific Tuberculosis Drug Market Share Value by Country, 2016–2026 ($Million)

TABLE 34         Asia-Pacific Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 35         Asia-Pacific Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 36         Japan Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 37         Japan Tuberculosis Drug Market Share by Therapy, 2016–2026 ($Million)

TABLE 38         China Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 39         China Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 40         Australia Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 41         Australia Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 42         India Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 43         India Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 44         South Korea Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 45         South Korea Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 46         Rest of Asia-Pacific Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 47         Rest of Asia-Pacific Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 48         LAMEA Tuberculosis Drug Market Share Value by Country, 2016–2026 ($Million)

TABLE 49         LAMEA Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 50         LAMEA Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 51         Saudi Arabia Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 52         Saudi Arabia Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 53         South Africa Tuberculosis Drug Market Share by Disease Type 2016–2026 ($Million)

TABLE 54         South Africa Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 55         Brazil Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 56         Brazil Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

TABLE 57         Rest of LAMEA Tuberculosis Drug Market Share by Disease Type, 2016–2026 ($Million)

TABLE 58         Rest of LAMEA Tuberculosis Drug Market Share by Therapy 2016–2026 ($Million)

LIST OF FIGURES

FIGURE 1         Global Tuberculosis Drug Market Overview

FIGURE 2         Value Chain Analysis

FIGURE 3         Bargaining Power of Suppliers

FIGURE 4         Bargaining Power of Buyers

FIGURE 5         Threat of Substitutes

FIGURE 6         Threat of New Entrants

FIGURE 7         Competitive Rivalry

FIGURE 8         Tuberculosis Drug Market, Market Share Analysis, 2018

FIGURE 9         Global Tuberculosis Drug Market, 2016–2026

FIGURE 10       U.S. Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 11       Canada Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 12       Mexico Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 13       Germany Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 14       France Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 15       U.K. Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 16       Italy Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 17       Spain Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 18       Rest of Europe Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 19       Japan Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 20       China Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 21       Australia Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 22       India Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 23       South Korea Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 24       Rest of Asia-Pacific Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 25       Saudi Arabia Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 26       South Africa Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 27       Brazil Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 28       Rest of LAMEA Tuberculosis Drug Market Share, 2016–2026 ($Million)

FIGURE 29       Sigma Pharmaceutical Pty Limited: Revenue Analysis, ($ million)

FIGURE 30       Sigma Pharmaceutical Pty Limited: Segment Revenue 2017 (%)